← All stocks

MEDIFAST INC

MED Net selling
CIK 0000910329 #4193 in the set updated 17 Sep 2026
Bought (120 mo)
$6.74M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$62.14M
$0.00 on a plan · $2.22M straight out of an exercise
Sold at will
$59.91M
97 of 104 sales
Net
−$55.40M
−$53.17M against sales at will

By person

21 insiders · 206 transactions
2.5×

Daniel R. Chard holds only 2.5 times base salary in stock. $2.53M of shares against $1.00M in salary for 2025.

Salary from the company's own proxy. The shares are what Daniel R. Chard last reported holding, valued at $12.26, the price Common Stock was last bought or sold at on the open market here, on 26 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Welling Glenn W.
Director
$2.07M (8)
$34.02M (4)
−$31.94M
269,858
2.41%
$3.31M
−63.5%
Chard Daniel R
Chairman & CEO
$540.84K (5)
$9.75M (45)
−$9.21M
205,911
1.84%
$2.53M
MACDONALD MICHAEL C
Director
$8.47M (30)
−$8.47M
275,979
2.47%
$3.38M
−18.7%
HALLQUIST CONSTANCE J.
Former Director
$3.44K (3)
$2.24M (6) scheduled
−$2.23M
9,743
0.0871%
$119.48K
−7.3%
SCHLACKMAN SCOTT
Director
$73.53K (7)
$1.63M (10) scheduled
−$1.56M
42,229
0.3777%
$517.86K
+1,440%
Kiai Parsa
Director
$1.42M (8)
+$1.42M
58,682
0.5249%
$719.63K
CONNOLLY CHARLES P
Director
$1.40M (2)
−$1.40M
41,374
0.3700%
$507.38K
−12.5%
BROWN JEFFREY J
Director
$2.58M (45)
$3.49M (3)
−$916.41K
73,568
0.6580%
$902.18K
+116.3%
SASSANO CARL E
Director
$799.70K (2)
−$799.70K
18,199
0.1628%
$223.18K
+93.2%
Thomas Andrea B
Director
$10.22K (5)
$200.46K (1)
−$190.24K
35,697
0.3193%
$437.76K
BYRNES KEVIN G
Director
$149.40K (1)
−$149.40K
14,922
0.1335%
$182.99K
+386.1%
Hoer Michael A.
Director
$41.33K (6)
+$41.33K
26,139
0.2338%
$320.55K
Maloney James P.
Chief Financial Officer
73,033
0.6532%
$895.62K
ROBINSON TIMOTHY G
Chief Financial Officer
47,214
0.4223%
$578.99K
+139.2%
Geary Elizabeth A.
Director
31,225
0.2793%
$382.92K
MacKenzie Jonathan Barrett
VP, Finance & CAO
20,838
0.1864%
$255.54K
Rose Jeffrey Matthew
Director
18,419
0.1647%
$225.88K
AMELI MEHRNAZ MONA
President, OPTAVIA
10,809
0.0967%
$132.55K
+35.9%
HARTWIG JORGENE K.
Director
9,808
0.0877%
$120.28K
+110.0%
KELLEMAN JOSEPH P
Vice President of Finance
2,355
0.0211%
$28.88K
+17.8%
Johnson Stephen Kyle
VP, Finance & CAO
665
0.0059%
$8.16K
Insider
Date
Role
Action
Shares
Price
Amount
SCHLACKMAN SCOTT
8 Mar 2024
Director
Sold after exercise
2,753
$39.46
$108.63K
SCHLACKMAN SCOTT
8 Mar 2024
Director
Sold after exercise
1,300
$39.41
$51.23K
SCHLACKMAN SCOTT
10 Mar 2023
Director
Sold after exercise
2,200
$108.68
$239.10K
HALLQUIST CONSTANCE J.
3 Mar 2021
Director
Sold after exercise
4,500
$259.02
$1.17M
SCHLACKMAN SCOTT
4 Jun 2020
Director
Sold after exercise
1,500
$107.77
$161.66K
SCHLACKMAN SCOTT
4 Jun 2020
Director
Sold after exercise
1,619
$107.35
$173.80K
SCHLACKMAN SCOTT
5 Mar 2019
Director
Sold after exercise
2,500
$129.80
$324.50K

What was left out

Form 4 filings counted 237
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 7
Sales at will 97
Transactions with no price 0
Shares from compensation/vesting 1,652,696
Sales filed before the plan box existed 93
History held since 4 Oct 2016